Establishing subclasses of childhood eczema, their risk factors and prognosis.

"CONFLICTS OF INTEREST D.J. Lopez has nothing to disclose. Dr N.T. Waidyatillake has nothing to disclose. Dr J.C. Su has nothing to disclose. Prof C. Svanes has nothing to disclose. Dr B. Erbas has nothing to disclose. Prof S. C Dharmage, A/Prof A.J. Lowe, Dr J. Perret, A/Prof C.J. Lodge, Dr D.S. Bui and Prof M.J. Abramson have received an investigator‐initiated grant from GlaxoSmithKline for unrelated research. Prof M.J. Abramson holds investigator‐initiated grants for unrelated research from Pfizer, Boehringer‐Ingelheim and Sanofi. He has undertaken an unrelated consultancy for and received assistance with conference attendance from Sanofi. He has also received a speaker's fee from GSK. A/Prof A.J. Lowe has received in‐kind contributions of emollients from PuraCap and Primus for use in eczema prevention trials that he leads."

"Funding information"